Search Results - "Van Maaren, Marissa C"

Explainable machine learning can outperform Cox regression predictions and provide insights in breast cancer survival by Moncada-Torres, Arturo, van Maaren, Marissa C., Hendriks, Mathijs P., Siesling, Sabine, Geleijnse, Gijs

“…Cox Proportional Hazards (CPH) analysis is the standard for survival analysis in oncology. Recently, several machine learning (ML) techniques have been adapted…”
Get full text

10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study by van Maaren, Marissa C, MSc, de Munck, Linda, MSc, de Bock, Geertruida H, Prof, Jobsen, Jan J, PhD, van Dalen, Thijs, PhD, Linn, Sabine C, Prof, Poortmans, Philip, Prof, Strobbe, Luc J A, PhD, Siesling, Sabine, Prof

“…Summary Background Investigators of registry-based studies report improved survival for breast-conserving surgery plus radiotherapy compared with mastectomy in…”
Get full text

Implementation of ultra-hypofractionated radiotherapy schedules for breast cancer during the COVID-19 pandemic in the Netherlands by Eijkelboom, Anouk H., Stam, Marcel R., van den Bongard, Desirée H.J.G., Sattler, Margriet G.A., Bantema-Joppe, Enja J., Siesling, Sabine, van Maaren, Marissa C.

“…•The COVID pandemic led to the early use of ultra-hypofractionated radiotherapy.•Use of 5 fractions increased after recommendation by the Dutch radiotherapy…”
Get full text

Representativeness of trial participants: linking the EORTC boost-no boost trial to the Netherlands cancer registry by Neven, Anouk, van Maaren, Marissa C., Schreuder, Kay, Kranse, Ries, Struikmans, Henk, Poortmans, Philip M., Bartelink, Harry, Collette, Laurence, Liu, Lifang, Siesling, Sabine

“…To evaluate the representativeness of Dutch patients participating in the European Organization for Research and Treatment of Cancer EORTC boost-no-boost trial…”
Get full text

Associations between treatments, comorbidities and multidimensional aspects of quality of life among patients with advanced cancer in the Netherlands—a 2017–2020 multicentre cross-sectional study by Malhotra, Ananya, Fransen, Heidi P., Quaresma, Manuela, Raijmakers, Natasja, Versluis, Moyke A. J., Rachet, Bernard, van Maaren, Marissa C., Leyrat, Clémence

“…Objective To investigate associations between quality of life (QoL) and 1) immunotherapy and other cancer treatments received three months before QoL…”
Get full text

Improved risk estimation of locoregional recurrence, secondary contralateral tumors and distant metastases in early breast cancer: the INFLUENCE 2.0 model by Völkel, Vinzenz, Hueting, Tom A., Draeger, Teresa, van Maaren, Marissa C., de Munck, Linda, Strobbe, Luc J. A., Sonke, Gabe S., Schmidt, Marjanka K., van Hezewijk, Marjan, Groothuis-Oudshoorn, Catharina G. M., Siesling, Sabine

“…Purpose To extend the functionality of the existing INFLUENCE nomogram for locoregional recurrence (LRR) of breast cancer toward the prediction of secondary…”
Get full text

External validation of 87 clinical prediction models supporting clinical decisions for breast cancer patients by Hueting, Tom A., van Maaren, Marissa C., Hendriks, Mathijs P., Koffijberg, Hendrik, Siesling, Sabine

“…Numerous prediction models have been developed to support treatment-related decisions for breast cancer patients. External validation, a prerequisite for…”
Get full text

Ten-year conditional recurrence risks and overall and relative survival for breast cancer patients in the Netherlands: Taking account of event-free years by van Maaren, Marissa C., Strobbe, Luc J.A., Smidt, Marjolein L., Moossdorff, Martine, Poortmans, Philip M.P., Siesling, Sabine

“…Survival estimates from diagnosis are of limited importance for (ex-)breast cancer patients who survived several years, as it includes information on already…”
Get full text

The use and misuse of risk prediction tools for clinical decision-making by van Maaren, Marissa C., Hueting, Tom A., Völkel, Vinzenz, van Hezewijk, Marjan, Strobbe, Luc JA, Siesling, Sabine

Get full text

Trends in incidence, treatment, survival and subsequent breast cancer in lobular carcinoma in situ in the Netherlands: A population-based analysis by van Maaren, Marissa C., Ávila, Agustín Ortega, van Manen, Jeannette G., Menke-Pluijmers, Marian BE, Veltman, Jeroen, Bart, Joost, Westenend, Pieter J., Siesling, Sabine

“…We analysed incidence, treatment, survival, occurrence of ductal carcinoma in situ (DCIS) and invasive breast cancer (IBC) after lobular carcinoma in situ…”
Get full text

Quantifying the Mitigating Effects of Whole-Breast Radiotherapy and Systemic Treatments on Regional Recurrence Incidence Among Breast Cancer Patients by van Steenhoven, Julia E. C., Kuijer, Anne, van Maaren, Marissa C., Roos, Marleen, Elias, Sjoerd G., van Diest, Paul J., Siesling, Sabine, Smidt, Marjolein L., Boersma, Liesbeth J., van Dalen, Thijs

“…Background Despite the potential for residual lymph node metastases after a negative or positive sentinel lymph node biopsy (SLNB), breast cancer patients…”
Get full text

Facilitating validation of prediction models: a comparison of manual and semi-automated validation using registry-based data of breast cancer patients in the Netherlands by van Steenbeek, Cornelia D, van Maaren, Marissa C, Siesling, Sabine, Witteveen, Annemieke, Verbeek, Xander A A M, Koffijberg, Hendrik

“…Clinical prediction models are not routinely validated. To facilitate validation procedures, the online Evidencio platform ( https://www.evidencio.com ) has…”
Get full text

Heart failure medication after a first hospital admission and risk of heart failure readmission, focus on beta-blockers and renin-angiotensin-aldosterone system medication: A retrospective cohort study in linked databases by Kruik-Kollöffel, Willemien J, van der Palen, Job, Doggen, Carine J M, van Maaren, Marissa C, Kruik, H Joost, Heintjes, Edith M, Movig, Kris L L, Linssen, Gerard C M

“…This study assessed the association between heart failure (HF) medication (angiotensin-converting-enzyme inhibitors (ACEI)/angiotensin-receptor blockers (ARB),…”
Get full text

Which real indications remain for mastectomy? by Cardoso, Maria Joao, de Boniface, Jana, Dodwell, David, Kaidar-Person, Orit, Poortmans, Philip, van Maaren, Marissa C.

“…© 2024 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/…”
Get full text

A conditional model predicting the 10-year annual extra mortality risk compared to the general population: a large population-based study in Dutch breast cancer patients by van Maaren, Marissa C, Kneepkens, Robert F, Verbaan, Joke, Huijgens, Peter C, Lemmens, Valery E P P, Verhoeven, Rob H A, Siesling, Sabine

“…Many cancer survivors are facing difficulties in getting a life insurance; raised premiums and declinatures are common. We generated a prediction model…”
Get full text

Breast conserving therapy and mastectomy revisited: Breast cancer‐specific survival and the influence of prognostic factors in 129,692 patients by Lagendijk, Mirelle, van Maaren, Marissa C., Saadatmand, Sepideh, Strobbe, Luc J.A., Poortmans, Philip M.P., Koppert, Linetta B., Tilanus‐Linthorst, Madeleine M.A., Siesling, Sabine

“…This large population‐based study compared breast‐conserving surgery with radiation therapy (BCT) with mastectomy on (long‐term) breast cancer‐specific (BCSS)…”
Get full text

Ten‐year recurrence rates for breast cancer subtypes in the Netherlands: A large population‐based study by Maaren, Marissa C., Munck, Linda, Strobbe, Luc J.A., Sonke, Gabe S., Westenend, Pieter J., Smidt, Marjolein L., Poortmans, Philip M.P., Siesling, Sabine

“…Here we report for the first time the relation between breast cancer subtypes and 10‐year recurrence rates and mortality in the Netherlands. All operated women…”
Get full text

The majority of 922 prediction models supporting breast cancer decision-making are at high risk of bias by Hueting, Tom A., van Maaren, Marissa C., Hendriks, Mathijs P., Koffijberg, Hendrik, Siesling, Sabine

“…To systematically review the currently available prediction models that may support treatment decision-making in breast cancer. Literature was systematically…”
Get full text

Routine and interval detection of locoregional breast cancer recurrences and risk of subsequent distant metastasis by Eijkelboom, Anouk H., de Munck, Linda, de Vries, Maaike, Francken, Anne Brecht, Hendriks, Mathijs P., Strobbe, Luc, Witteveen, Annemieke, van Maaren, Marissa C., Siesling, Sabine

“…Purpose Follow-up for breast cancer survivors consists of after care and surveillance. The benefits of routine surveillance visits remain debatable. In this…”
Get full text

Comprehensive trends in incidence, treatment, survival and mortality of first primary invasive breast cancer stratified by age, stage and receptor subtype in the Netherlands between 1989 and 2017 by Meer, Daniël J., Kramer, Iris, Maaren, Marissa C., Diest, Paul J., Linn, Sabine, Maduro, John H., Strobbe, Luc, Siesling, Sabine, Schmidt, Marjanka K., Voogd, Adri C.

“…Our study aimed to provide a comprehensive overview of trends in incidence, survival, mortality and treatment of first primary invasive breast cancer (BC),…”
Get full text